B. Adler, S. Ashkar, H. Cantor, G. Weber (2001)
Costimulation by extracellular matrix proteins determines the response to TCR ligation.Cellular immunology, 210 1
S. North, M. Moenner, A. Bikfalvi (2005)
Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors.Cancer letters, 218 1
P. Farmer, H. Bonnefoi, P. Anderle, D. Cameron, P. Wirapati, V. Bécette, S. André, M. Piccart, M. Campone, E. Brain, G. MacGrogan, T. Petit, J. Jassem, F. Bibeau, E. Blot, J. Bogaerts, M. Aguet, J. Bergh, R. Iggo, M. Delorenzi (2009)
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancerNature Medicine, 15
K. Tanabe, A. Lemoine, D. Finkelstein, H. Kawasaki, T. Fujii, R. Chung, G. Lauwers, Y. Kulu, A. Muzikansky, D. Kuruppu, M. Lanuti, Jonathan Goodwin, D. Azoulay, B. Fuchs (2008)
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.JAMA, 299 1
T. Luedde, R. Schwabe (2011)
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinomaNature Reviews Gastroenterology &Hepatology, 8
L. Yates, P. Campbell (2012)
Evolution of the cancer genomeNature Reviews Genetics, 13
D. DeNardo, D. DeNardo, D. Brennan, E. Rexhepaj, B. Ruffell, S. Shiao, S. Madden, W. Gallagher, Nikhil Wadhwani, Scott Keil, Sharfaa Junaid, H. Rugo, E. Hwang, K. Jirström, B. West, L. Coussens (2011)
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.Cancer discovery, 1 1
C. Chia, Ke-chen Ban, H. Ithnin, Harjit Singh, R. Krishnan, Suryati Mokhtar, Nik Malihan, H. Seow (2002)
Expression of interleukin-18, interferon-γ and interleukin-10 in hepatocellular carcinomaImmunology Letters, 84
A. Jemal, F. Bray, Melissa Center, J. Ferlay, Elizabeth Ward, D. Forman (2011)
Global cancer statisticsCA: A Cancer Journal for Clinicians, 61
A. Sergio, C. Cristofori, R. Cardin, G. Pivetta, R. Ragazzi, A. Baldan, L. Girardi, U. Cillo, P. Burra, A. Giacomin, F. Farinati (2008)
Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and InvasivenessThe American Journal of Gastroenterology, 103
M. Allinen, R. Beroukhim, Li Cai, C. Brennan, J. Lahti-Domenici, Haiyan Huang, D. Porter, Min Hu, L. Chin, A. Richardson, S. Schnitt, W. Sellers, K. Polyak (2004)
Molecular characterization of the tumor microenvironment in breast cancer.Cancer cell, 6 1
Cécile Guichard, G. Amaddeo, S. Imbeaud, Y. Ladeiro, L. Pelletier, I. Maad, J. Calderaro, P. Bioulac-Sage, M. Letexier, F. Degos, B. Clement, C. Balabaud, É. Chevet, A. Laurent, G. Couchy, E. Letouzé, F. Calvo, J. Zucman‐Rossi (2012)
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinomaNature Genetics, 44
S. Coulon, F. Heindryckx, A. Geerts, C. Steenkiste, I. Colle, H. Vlierberghe (2011)
Angiogenesis in chronic liver disease and its complicationsLiver International, 31
K. Nicholson, N. Anderson (2002)
The protein kinase B/Akt signalling pathway in human malignancy.Cellular signalling, 14 5
D. Dapito, Ali Mencin, G. Gwak, G. Gwak, J. Pradère, M. Jang, I. Mederacke, J. Caviglia, Hossein Khiabanian, Adebowale Adeyemi, R. Bataller, J. Lefkowitch, Maureen Bower, R. Friedman, R. Sartor, R. Rabadán, R. Schwabe (2012)
Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.Cancer cell, 21 4
Josep 2, Myron Schwartz2, Vincenzo Mazzaferro3 (2005)
Resection and Liver Transplantation for Hepatocellular CarcinomaSeminars in Liver Disease, 25
Hui‐Lu Zhang, Le-xing Yu, Wen Yang, L. Tang, Yan Lin, Han Wu, B. Zhai, Ye-Xiong Tan, Lei Shan, Qiong Liu, Haiyang Chen, R. Dai, Bijun Qiu, Ya-qin He, Chao Wang, Long-yi Zheng, Yu-qiong Li, Fuquan Wu, Zhong Li, Hexin Yan, Hong-Yang Wang (2012)
Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats.Journal of hepatology, 57 4
Christina Eng, Robert Abraham (2011)
The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogrammingOncogene, 30
G. Adams, R. Martin, Ian Alley, Karissa Chabner, Kenneth Cohen, L. Calvi, H. Kronenberg, D. Scadden (2007)
Therapeutic targeting of a stem cell nicheNature Biotechnology, 25
Buckminster Farrow, B. Evers (2002)
Inflammation and the development of pancreatic cancer.Surgical oncology, 10 4
L. Qin (2012)
Inflammatory Immune Responses in Tumor Microenvironment and Metastasis of Hepatocellular CarcinomaCancer Microenvironment, 5
J. Massagué (2008)
TGFβ in CancerCell, 134
L. Mishra, Tanuj Banker, Joseph Murray, S. Byers, Arun Thenappan, A. He, K. Shetty, L. Johnson, E. Reddy (2009)
Liver stem cells and hepatocellular carcinomaHepatology, 49
Hoshida (2009)
Gene expression signature predicts outcome of liver cirrhosis (abstr)Hepatology, 50
Jens Marquardt1, Snorri Thorgeirsson1 (2010)
Stem Cells in Hepatocarcinogenesis: Evidence from Genomic DataSemin Liver Dis, 30
Hang Shi, M. Kokoeva, K. Inouye, Iphigenia Tzameli, Huali Yin, J. Flier (2006)
TLR4 links innate immunity and fatty acid-induced insulin resistance.The Journal of clinical investigation, 116 11
Tong Ding, Jing Xu, F. Wang, M. Shi, Ying Zhang, Sheng-ping Li, Limin Zheng (2009)
High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.Human pathology, 40 3
J. Schrader, T. Gordon-Walker, R. Aucott, M. Deemter, A. Quaas, Shaun Walsh, D. Benten, S. Forbes, R. Wells, J. Iredale (2011)
Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cellsHepatology, 53
R. Jiang, Z. Tan, L. Deng, Yun Chen, Yongxiang Xia, Yun Gao, Xuehao Wang, Beicheng Sun (2011)
Interleukin‐22 promotes human hepatocellular carcinoma by activation of STAT3Hepatology, 54
T. Lee, A. Castilho, V. Cheung, K. Tang, Stephanie Ma, I. Ng (2011)
CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.Cell stem cell, 9 1
RE Hewitt, DG Powe, K. Morrell, E. Balley, IH Leach, IO Ellis, DR Turner (1997)
Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast.British Journal of Cancer, 75
Llovet (2003)
Hepatocellular carcinomaLancet, 362
Jun‐liang Fu, Dongping Xu, Zhen-wen Liu, M. Shi, P. Zhao, B. Fu, Zheng Zhang, Hui-ying Yang, Hui Zhang, Chun-Bao Zhou, Jin-xia Yao, Lei Jin, Huifen Wang, Yongping Yang, Yang Fu, Fuluo Wang (2007)
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.Gastroenterology, 132 7
D. Bronzert, P. Pantazis, H. Antoniades, A. Kasid, N. Davidson, R. Dickson, M. Lippman (1987)
Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines.Proceedings of the National Academy of Sciences of the United States of America, 84 16
N. Bhowmick, A. Chytil, David Plieth, Agnieszka Gorska, N. Dumont, S. Shappell, M. Washington, E. Neilson, H. Moses (2004)
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent EpitheliaScience, 303
Jing-Ping Zhang, Jing Yan, Jing Xu, X. Pang, Minshan Chen, Li Li, Changyou Wu, Sheng-ping Li, Limin Zheng (2009)
Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.Journal of hepatology, 50 5
A. Trimboli, Carmen Cantemir-Stone, Fu Li, J. Wallace, Anand Merchant, Nicholas Creasap, John Thompson, Enrico Caserta, Hui Wang, Jean-Leon Chong, S. Naidu, G. Wei, Sudarshana Sharma, J. Stephens, S. Fernandez, M. Gurcan, M. Weinstein, S. Barsky, L. Yee, T. Rosol, P. Stromberg, M. Robinson, F. Pépin, M. Hallett, Morag Park, Michael Ostrowski, G. Leone (2009)
Pten in Stromal Fibroblasts Suppresses Mammary Epithelial TumorsNature, 461
G. Semenza (2011)
Oxygen sensing, homeostasis, and disease.The New England journal of medicine, 365 6
M. Abou-Shady, H. Baer, H. Friess, P. Berberat, A. Zimmermann, H. Graber, L. Gold, M. Korc, M. Büchler (1999)
Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.American journal of surgery, 177 3
P. Kaposi-Novák, Ju-Seog Lee, L. Gómez-Quiroz, C. Coulouarn, V. Factor, S. Thorgeirsson (2006)
Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype.The Journal of clinical investigation, 116 6
B. Dayyeh, May Yang, B. Fuchs, Daniel Karl, S. Yamada, J. Sninsky, T. O'Brien, J. Dienstag, K. Tanabe, R. Chung (2011)
A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.Gastroenterology, 141 1
R. Kalluri, M. Zeisberg (2006)
Fibroblasts in cancerNature Reviews Cancer, 6
V. Neaud, S. Faouzi, J. Guirouilh, B. Bail, C. Balabaud, P. Bioulac-Sage, J. Rosenbaum (1997)
Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: Evidence for a role of hepatocyte growth factorHepatology, 26
Jinmai Jiang, Yuriy Gusev, Ileana Aderca, Teresa Mettler, D. Nagorney, D. Brackett, L. Roberts, Thomas Schmittgen (2008)
Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient SurvivalClinical Cancer Research, 14
Ju-Seog Lee, Jeonghoon Heo, L. Libbrecht, I. Chu, P. Kaposi-Novák, D. Calvisi, A. Mikaelyan, L. Roberts, A. Demetris, Zong-tang Sun, F. Nevens, T. Roskams, S. Thorgeirsson (2006)
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cellsNature Medicine, 12
M. Anson, A. Crain‐Denoyelle, V. Baud, F. Chereau, Angélique Gougelet, B. Terris, S. Yamagoe, S. Colnot, M. Viguier, C. Perret, J. Couty (2012)
Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice.The Journal of clinical investigation, 122 2
I. Melero, B. Sangro, J. Riezu-Boj, M. Iñarrairaegui, J. Lasarte, P. Sarobe, E. Larrea, J. Prieto (2012)
Abstract 4387: Antiviral and antitumoral effects of the anti-CTLA4 agent tremelimumab in patients with hepatocellular carcinoma (HCC) and chronic hepatitis C virus (HCV) infection: Results from a phase II clinical trialCancer Research, 72
J. Llovet, C. Peña, C. Lathia, M. Shan, G. Meinhardt, J. Bruix (2012)
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular CarcinomaClinical Cancer Research, 18
E. Roussos, J. Condeelis, A. Patsialou (2011)
Chemotaxis in cancerNature Reviews Cancer, 11
J. Pollard (2009)
Trophic macrophages in development and diseaseNature Reviews Immunology, 9
Z. Yang, D. Ho, M. Ng, C. Lau, W. Yu, P. Ngai, P. Chu, C. Lam, R. Poon, S. Fan (2008)
Significance of CD90+ cancer stem cells in human liver cancer.Cancer cell, 13 2
A. Villanueva, Y. Hoshida, S. Toffanin, A. Lachenmayer, Clara Alsinet, R. Savić, H. Cornellà, J. Llovet (2010)
New Strategies in Hepatocellular Carcinoma: Genomic Prognostic MarkersClinical Cancer Research, 16
Hui Liu, Z. Pan, Ai-Jun Li, S. Fu, Yin Lei, Hangyong Sun, Mengchao Wu, Weiping Zhou (2008)
Roles of Chemokine Receptor 4 (CXCR4) and Chemokine Ligand 12 (CXCL12) in Metastasis of Hepatocellular Carcinoma CellsCellular and Molecular Immunology, 5
Le-xing Yu, Hexin Yan, Qiong Liu, Wen Yang, Hong-ping Wu, W. Dong, L. Tang, Yan Lin, Ya-qin He, Shanshan Zou, Chao Wang, Hui‐Lu Zhang, G. Cao, Meng-chao Wu, Hong-Yang Wang (2010)
Endotoxin accumulation prevents carcinogen‐induced apoptosis and promotes liver tumorigenesis in rodentsHepatology, 52
S. Chen, S. Akbar, K. Tanimoto, T. Ninomiya, H. Iuchi, K. Michitaka, N. Horiike, M. Onji (2000)
Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis.Cancer letters, 148 1
G. Giannelli, C. Bergamini, F. Marinosci, E. Fransvea, M. Quaranta, L. Lupo, O. Schiraldi, S. Antonaci (2002)
Clinical role of MMP‐2/TIMP‐2 imbalance in hepatocellular carcinomaInternational Journal of Cancer, 97
S. Boyault, D. Rickman, A. Reyniès, C. Balabaud, S. Rebouissou, E. Jeannot, A. Hérault, J. Saric, J. Belghiti, D. Franco, P. Bioulac-Sage, P. Laurent-Puig, J. Zucman‐Rossi (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targetsHepatology, 45
E. Schiffer, C. Housset, W. Cacheux, D. Wendum, C. Desbois-Mouthon, C. Rey, F. Clergue, R. Poupon, V. Barbu, O. Rosmorduc (2005)
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosisHepatology, 41
T. Lucas, D. Abraham, S. Aharinejad (2008)
Modulation of tumor associated macrophages in solid tumors.Frontiers in bioscience : a journal and virtual library, 13
K. Frese, D. Tuveson (2007)
Maximizing mouse cancer modelsNature Reviews Cancer, 7
A. Villanueva, J. Llovet (2012)
Second-Line Therapies in Hepatocellular Carcinoma: Emergence of Resistance to SorafenibClinical Cancer Research, 18
A. Zhu (2012)
Molecularly targeted therapy for advanced hepatocellular carcinoma in 2012: current status and future perspectives.Seminars in oncology, 39 4
M. Mejías, E. García-Pras, C. Tiani, R. Miquel, J. Bosch, Mercedes Fernandez (2009)
Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic ratsHepatology, 49
A. Villanueva, J. Llovet (2011)
Targeted therapies for hepatocellular carcinoma.Gastroenterology, 140 5
T. Amann, F. Bataille, T. Spruss, K. Dettmer, P. Wild, C. Liedtke, Marcus Mühlbauer, P. Kiefer, P. Oefner, C. Trautwein, A. Bosserhoff, C. Hellerbrand (2010)
Tumorigenesis and Neoplastic Progression Reduced Expression of Fibroblast Growth Factor Receptor 2 IIIb in Hepatocellular Carcinoma Induces a More Aggressive Growth
E. Gherardi, W. Birchmeier, C. Birchmeier, G. Woude (2012)
Targeting MET in cancer: rationale and progressNature Reviews Cancer, 12
Valerie Chew, Jinmiao Chen, D. Lee, E. Loh, Joyce Lee, K. Lim, A. Weber, K. Slankamenac, R. Poon, Henry Yang, L. Ooi, H. Toh, M. Heikenwalder, I. Ng, A. Nardin, J. Abastado (2011)
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinomaGut, 61
M. Katzenellenbogen, Lina Mizrahi, O. Pappo, Naama Klopstock, Devorah Olam, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, E. Domany, E. Galun, D. Goldenberg (2007)
Molecular Mechanisms of Liver Carcinogenesis in the Mdr2-Knockout MiceMolecular Cancer Research, 5
A. Budhu, X. Wang (2006)
The role of cytokines in hepatocellular carcinomaJournal of Leukocyte Biology, 80
S. Beckebaum, Xia Zhang, Xiao Chen, Zhengya Yu, A. Frilling, G. Dworacki, H. Grosse-wilde, C. Broelsch, G. Gerken, V. Cicinnati (2004)
Increased Levels of Interleukin-10 in Serum from Patients with Hepatocellular Carcinoma Correlate with Profound Numerical Deficiencies and Immature Phenotype of Circulating Dendritic Cell SubsetsClinical Cancer Research, 10
G. Semenza (2011)
mechanisms of disease Oxygen Sensing , Homeostasis , and Disease
S. Friedman (2008)
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.Physiological reviews, 88 1
E. Pikarsky, R. Porat, I. Stein, R. Abramovitch, S. Amit, Shafika Kasem, Elena Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, Y. Ben-Neriah (2004)
NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 431
Wei Li, Enrique Gomez, Zhiqiang Zhang (2007)
Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma.Journal of experimental & clinical cancer research : CR, 26 4
S. Maeda, H. Kamata, Jun-Li Luo, H. Leffert, M. Karin (2005)
IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical HepatocarcinogenesisCell, 121
Haijun Zhou, Hua Huang, Jiong Shi, Yue Zhao, Q. Dong, H. Jia, Yin‐kun Liu, Q. Ye, Huichuan Sun, Xiao-dong Zhu, L. Fu, K. Guo, Dongmei Gao, Jian Sun, Zhao-wei Yan, N. Ren, Zhao-You Tang, L. Qin (2010)
Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resectionGut, 59
A. Patócs, Li Zhang, Yaomin Xu, F. Weber, T. Caldés, G. Mutter, Petra Platzer, C. Eng (2007)
Breast-cancer stromal cells with TP53 mutations and nodal metastases.The New England journal of medicine, 357 25
J. Gordan, Craig B. Thompson, M. Simon (2007)
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation.Cancer cell, 12 2
H. Seitz, F. Stickel (2006)
Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress, 387
M. Okamoto, T. Utsunomiya, S. Wakiyama, M. Hashimoto, K. Fukuzawa, T. Ezaki, T. Hanai, H. Inoue, M. Mori (2006)
Specific Gene-Expression Profiles of Noncancerous Liver Tissue Predict the Risk for Multicentric Occurrence of Hepatocellular Carcinoma in Hepatitis C Virus–Positive PatientsAnnals of Surgical Oncology, 13
J. Condeelis, J. Segall (2003)
Intravital imaging of cell movement in tumoursNature Reviews Cancer, 3
F. Heindryckx, I. Colle, H. Vlierberghe (2009)
Experimental mouse models for hepatocellular carcinoma researchInternational Journal of Experimental Pathology, 90
T. Fiaschi, P. Chiarugi (2012)
Oxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic LiaisonInternational Journal of Cell Biology, 2012
M. Sherman (2008)
Recurrence of hepatocellular carcinoma.The New England journal of medicine, 359 19
Changqing Yang, M. Zeisberg, Julie Lively, P. Nyberg, N. Afdhal, R. Kalluri (2003)
Integrin α1β1 and α2β1 Are the Key Regulators of Hepatocarcinoma Cell Invasion Across the Fibrotic Matrix MicroenvironmentCancer Research, 63
C. Shachaf, Andrew Kopelman, Constadina Arvanitis, Åsa Karlsson, S. Beer, S. Mandl, Michael Bachmann, A. Borowsky, B. Ruebner, R. Cardiff, Qiwei Yang, J. Bishop, C. Contag, D. Felsher (2004)
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancerNature, 431
Yang (2003)
Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironmentCancer Res, 63
J. Campbell, S. Hughes, D. Gilbertson, T. Palmer, M. Holdren, Aaron Haran, Melissa Odell, Renay Bauer, H. Ren, H. Haugen, M. Yeh, N. Fausto (2005)
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.Proceedings of the National Academy of Sciences of the United States of America, 102 9
Yao-hui Wang, Wei-min Wang, Lingyan Wang, Xiangdong Wang, J. Xia (2012)
Regulatory mechanisms of interleukin-8 production induced by tumour necrosis factor-α in human hepatocellular carcinoma cellsJournal of Cellular and Molecular Medicine, 16
Amann (2010)
Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growthAm J Pathol, 176
Guobin He, Guann-Yi Yu, V. Temkin, Hisanobu Ogata, C. Kuntzen, T. Sakurai, W. Sieghart, M. Peck‐Radosavljevic, H. Leffert, M. Karin (2010)
Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.Cancer cell, 17 3
H. Tilg, H. Tilg, A. Wilmer, A. Wilmer, W. Vogel, W. Vogel, M. Herold, M. Herold, B. Nölchen, B. Nölchen, G. Judmaier, G. Judmaier, C. Huber, C. Huber (1992)
Serum levels of cytokines in chronic liver diseases.Gastroenterology, 103 1
Douglas Hanahan, L. Coussens (2012)
Accessories to the crime: functions of cells recruited to the tumor microenvironment.Cancer cell, 21 3
S. Wilhelm, Lila Adnane, P. Newell, A. Villanueva, J. Llovet, M. Lynch (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signalingMolecular Cancer Therapeutics, 7
O. Pello, M. Pizzol, M. Mirolo, L. Soucek, L. Zammataro, A. Amabile, A. Doni, M. Nebuloni, L. Swigart, G. Evan, A. Mantovani, M. Locati (2012)
Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology.Blood, 119 2
A. Luca, A. Carotenuto, A. Rachiglio, M. Gallo, M. Maiello, D. Aldinucci, A. Pinto, N. Normanno (2008)
The role of the EGFR signaling in tumor microenvironmentJournal of Cellular Physiology, 214
Yi Ren, R. Poon, H. Tsui, Wenhui Chen, Zhi Li, C. Lau, Wun-Ching Yu, S. Fan (2003)
Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 16 Pt 1
Mauad (1994)
Mice with homozygous disruption of the mdr2 P-glycoprotein geneAm J Pathol, 145
Z. Yao, L. Mishra (2009)
Cancer stem cells and hepatocellular carcinomaCancer Biology & Therapy, 8
Ke Gong, Chao Chen, Y. Zhan, Yan Chen, Zebo Huang, Wenhua Li (2012)
Autophagy-related Gene 7 (ATG7) and Reactive Oxygen Species/Extracellular Signal-regulated Kinase Regulate Tetrandrine-induced Autophagy in Human Hepatocellular Carcinoma*The Journal of Biological Chemistry, 287
Y. Hoshida, S. Nijman, M. Kobayashi, J. Chan, Jean-Philippe Brunet, Derek Chiang, A. Villanueva, P. Newell, K. Ikeda, M. Hashimoto, G. Watanabe, S. Gabriel, S. Friedman, H. Kumada, J. Llovet, T. Golub (2009)
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.Cancer research, 69 18
A. Budhu, M. Forgues, Q. Ye, H. Jia, P. He, Krista Zanetti, U. Kammula, Yidong Chen, L. Qin, Zhao-You Tang, X. Wang (2006)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.Cancer cell, 10 2
Xiaohong Shen, Na Li, Hui Li, Ti Zhang, Feng Wang, Qiang Li (2010)
Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 136
M. Lisanti, U. Martinez-Outschoorn, Barbara Chiavarina, S. Pavlides, D. Whitaker‐Menezes, A. Tsirigos, A. Witkiewicz, Zhao Lin, Renee Balliet, A. Howell, F. Sotgia (2010)
Understanding the "lethal" drivers of tumor-stroma co-evolutionCancer Biology & Therapy, 10
T. Mauad, van Cm, K. Dingemans, Smit Jj, A. Schinkel, Notenboom Rg, van Ma, Verkruisen Rp, Groen Ak, Oude Rp (1994)
Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis.The American journal of pathology, 145 5
P. Bollyky, R. Wu, B. Falk, J. Lord, S. Long, A. Preisinger, Brandon Teng, G. Holt, N. Standifer, K. Braun, Cindy Xie, P. Samuels, R. Vernon, J. Gebe, T. Wight, G. Nepom (2011)
ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursorsProceedings of the National Academy of Sciences, 108
Wei Zhang, Xiao-dong Zhu, Hui-Chuan Sun, Y. Xiong, P. Zhuang, Hua-Xiang Xu, Ling-Qun Kong, Lu Wang, Wei-Zhong Wu, Zhao-You Tang (2010)
Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic EffectsClinical Cancer Research, 16
H. Baek, Sung-Chul Lim, K. Kitisin, W. Jogunoori, Yi Tang, M. Marshall, B. Mishra, Tae Kim, K. Cho, S. Kim, L. Mishra (2008)
Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesisHepatology, 48
Yinghong Shi, Zhen–Bin Ding, Jian Zhou, Bo Hui, G. Shi, A. Ke, Xiao-Ying Wang, Z. Dai, Yuan-fei Peng, Cheng-yu Gu, S. Qiu, Jia Fan (2011)
Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosisAutophagy, 7
Vivian Barry-Hamilton, Rhyannon Spangler, D. Marshall, S. McCauley, Hector Rodriguez, M. Oyasu, Amanda Mikels, M. Vaysberg, Haben Ghermazien, C. Wai, Carlos Garcia, Arleene Velayo, B. Jorgensen, Donna Biermann, Daniel Tsai, Jennifer Green, Shelly Zaffryar-Eilot, A. Holzer, S. Ogg, D. Thai, G. Neufeld, P. Vlasselaer, V. Smith (2010)
Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironmentNature Medicine, 16
Stephanie Ma, K. Chan, Liang Hu, T. Lee, J. Wo, I. Ng, B. Zheng, X. Guan (2007)
Identification and characterization of tumorigenic liver cancer stem/progenitor cells.Gastroenterology, 132 7
H. Yoshiji, S. Kuriyama, R. Noguchi, J. Yoshii, Y. Ikenaka, K. Yanase, T. Namisaki, Mitsuteru Kitade, M. Uemura, Tsutomu Masaki, Hiroshi Fukui (2005)
Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in miceGut, 54
Hye Kim, Sae Lee, G. Jung (2010)
The hepatitis B viral X protein activates NF‐κB signaling pathway through the up‐regulation of TBK1FEBS Letters, 584
Junfang Ji, X. Wang (2012)
Clinical implications of cancer stem cell biology in hepatocellular carcinoma.Seminars in oncology, 39 4
K. Levental, Hongmei Yu, L. Kass, J. Lakins, M. Egeblad, J. Erler, S. Fong, K. Csiszȧr, A. Giaccia, W. Weninger, M. Yamauchi, D. Gasser, V. Weaver (2009)
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin SignalingCell, 139
A. Orimo, Piyush Gupta, D. Sgroi, F. Arenzana‐Seisdedos, T. Delaunay, R. Naeem, V. Carey, A. Richardson, R. Weinberg (2005)
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 SecretionCell, 121
B. Zamarron, Wanjun Chen (2011)
Dual Roles of Immune Cells and Their Factors in Cancer Development and ProgressionInternational Journal of Biological Sciences, 7
Pengfei Lu, V. Weaver, Z. Werb (2012)
The extracellular matrix: A dynamic niche in cancer progressionThe Journal of Cell Biology, 196
Paolo Provenzano, K. Eliceiri, Jay Campbell, D. Inman, J. White, P. Keely (2006)
Collagen reorganization at the tumor-stromal interface facilitates local invasionBMC Medicine, 4
A. Orimo, R. Weinberg (2006)
Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell TypeCell Cycle, 5
Xiong-Zhi Wu, G. Xie, Dan Chen (2007)
Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 22
Ilona Kryczek, A. Lange, P. Mottram, Xavier Alvarez, P. Cheng, M. Hogan, L. Moons, Shuang Wei, L. Zou, V. Machelon, D. Émilie, Margarita Terrassa, A. Lackner, T. Curiel, P. Carmeliet, W. Zou (2005)
CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.Cancer research, 65 2
T. Yamashita, Junfang Ji, A. Budhu, M. Forgues, Wen Yang, Hong-Yang Wang, H. Jia, Q. Ye, L. Qin, E. Wauthier, L. Reid, H. Minato, M. Honda, S. Kaneko, Zhao-You Tang, X. Wang (2009)
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.Gastroenterology, 136 3
Gemma Migneco, D. Whitaker‐Menezes, Barbara Chiavarina, Remedios Castelló-Cros, S. Pavlides, R. Pestell, A. Fatatis, N. Flomenberg, A. Tsirigos, A. Howell, U. Martinez-Outschoorn, F. Sotgia, M. Lisanti (2010)
Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: Evidence for stromal-epithelial metabolic couplingCell Cycle, 9
B. Lichtenberger, Poi Tan, Heide Niederleithner, N. Ferrara, P. Petzelbauer, M. Sibilia (2010)
Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer DevelopmentCell, 140
Y. Hoshida, A. Villanueva, M. Kobayashi, J. Peix, Derek Chiang, Amy Camargo, Supriya Gupta, Jamie Moore, Matthew Wrobel, Jim Lerner, Michael Reich, J. Chan, J. Glickman, K. Ikeda, M. Hashimoto, G. Watanabe, M. Daidone, S. Roayaie, M. Schwartz, S. Thung, H. Salvesen, S. Gabriel, V. Mazzaferro, J. Bruix, S. Friedman, H. Kumada, J. Llovet, T. Golub (2008)
Gene expression in fixed tissues and outcome in hepatocellular carcinoma.The New England journal of medicine, 359 19
Li-dan Liu, Jannes Ulbrich, Judith Müller, T. Wüstefeld, L. Aeberhard, Theresia Kress, Nathiya Muthalagu, Lukas Rycak, Ramona Rudalska, R. Moll, S. Kempa, L. Zender, M. Eilers, D. Murphy (2012)
Deregulated MYC expression induces dependence upon AMPK-related kinase 5Nature, 483
A. Zhu, D. Duda, D. Sahani, R. Jain (2011)
HCC and angiogenesis: possible targets and future directionsNature Reviews Clinical Oncology, 8
J. Lecouter, D. Moritz, Bing Li, G. Phillips, X. Liang, H. Gerber, K. Hillan, N. Ferrara (2003)
Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1Science, 299
M. Mueller, N. Fusenig (2004)
Friends or foes — bipolar effects of the tumour stroma in cancerNature Reviews Cancer, 4
David Zhang, S. Friedman (2012)
Fibrosis‐dependent mechanisms of hepatocarcinogenesisHepatology, 56
J. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, J. Blanc, A. Oliveira, A. Santoro, J. Raoul, A. Forner, M. Schwartz, C. Porta, S. Zeuzem, L. Bolondi, T. Greten, P. Galle, J. Seitz, I. Borbath, D. Häussinger, T. Giannaris, M. Shan, M. Moscovici, D. Voliotis, J. Bruix (2008)
Sorafenib in advanced hepatocellular carcinoma.The New England journal of medicine, 359 4
Yan Li, Zhao-You Tang, Jin-xuan Hou (2012)
Hepatocellular carcinoma: insight from animal modelsNature Reviews Gastroenterology &Hepatology, 9
Sheng-Di Wu, Yushui Ma, Ying Fang, Li-Li Liu, D. Fu, X. Shen (2012)
Role of the microenvironment in hepatocellular carcinoma development and progression.Cancer treatment reviews, 38 3
Derek Chiang, A. Villanueva, Y. Hoshida, J. Peix, P. Newell, B. Mínguez, A. Leblanc, D. Donovan, S. Thung, M. Solé, V. Tovar, Clara Alsinet, A. Ramos, J. Barretina, S. Roayaie, M. Schwartz, S. Waxman, J. Bruix, V. Mazzaferro, A. Ligon, V. Najfeld, S. Friedman, W. Sellers, M. Meyerson, J. Llovet (2008)
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.Cancer research, 68 16
Yong-cang Wang, Ge-liang Xu, W. Jia, Sheng-jin Han, W. Ren, Wei Wang, Wen-bin Liu, Chuan-hai Zhang, Hao Chen (2011)
Estrogen Suppresses Metastasis in Rat Hepatocellular Carcinoma through Decreasing Interleukin-6 and Hepatocyte Growth Factor ExpressionInflammation, 35
T. Yamashita, M. Forgues, Wei Wang, J. Kim, Q. Ye, H. Jia, A. Budhu, Krista Zanetti, Yidong Chen, L. Qin, Zhao-You Tang, X. Wang (2008)
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.Cancer research, 68 5
A. Mazzocca, E. Fransvea, G. Lavezzari, S. Antonaci, G. Giannelli (2009)
Inhibition of transforming growth factor β receptor I kinase blocks hepatocellular carcinoma growth through neo‐angiogenesis regulationHepatology, 50
Nelson Fausto1, Jean Campbell1 (2010)
Mouse Models of Hepatocellular CarcinomaSemin Liver Dis, 30
H. Hashizume, P. Baluk, S. Morikawa, J. Mclean, G. Thurston, S. Roberge, R. Jain, D. McDonald (2000)
Openings between defective endothelial cells explain tumor vessel leakiness.The American journal of pathology, 156 4
J. Chung, Sun-Hoo Park, Seon Park, Eun-Ran Park, Pu-Hyeon Cha, Bu-Yeo Kim, Y. Chung, S. Woo, C. Han, Sang-Bum Kim, K. Suh, Ja-june Jang, Kyoungbun Lee, D. Choi, Sora Lee, G. Lee, K. Hahm, J. Shin, Byung Kim, K. Noh, Tae Kim, Kee‐Ho Lee, Y. Yoo (2012)
Overexpression of Romo1 promotes production of reactive oxygen species and invasiveness of hepatic tumor cells.Gastroenterology, 143 4
Zhen–Bin Ding, Yinghong Shi, Jian Zhou, S. Qiu, Yang Xu, Z. Dai, G. Shi, Xiao-Ying Wang, A. Ke, Bing Wu, Jia Fan (2008)
Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma.Cancer research, 68 22
Yuqing Liu, R. Poon, Qinyu Li, T. Kok, C. Lau, S. Fan (2005)
Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.Cancer research, 65 9
T. Sethi, R. Rintoul, S. Moore, A. MacKinnon, D. Salter, C. Choo, E. Chilvers, I. Dransfield, S. Donnelly, R. Strieter, C. Haslett (1999)
Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivoNature Medicine, 5
A. Sutton, V. Friand, S. Brulé-Donneger, Thomas Chaigneau, M. Ziol, O. Sainte-Catherine, Aurélie Poiré, L. Saffar, M. Kraemer, J. Vassy, P. Nahon, J. Salzmann, L. Gattegno, N. Charnaux (2007)
Stromal Cell–Derived Factor-1/Chemokine (C-X-C Motif) Ligand 12 Stimulates Human Hepatoma Cell Growth, Migration, and InvasionMolecular Cancer Research, 5
N. Sodir, L. Swigart, A. Karnezis, D. Hanahan, G. Evan, L. Soucek (2011)
Endogenous Myc maintains the tumor microenvironment.Genes & development, 25 9
J. Haybaeck, N. Zeller, M. Wolf, A. Weber, U. Wagner, M. Kurrer, J. Bremer, G. Iezzi, R. Graf, P. Clavien, R. Thimme, H. Blum, S. Nedospasov, K. Zatloukal, M. Ramzan, S. Ciesek, T. Pietschmann, P. Marche, M. Karin, M. Kopf, J. Browning, A. Aguzzi, M. Heikenwalder (2009)
A lymphotoxin-driven pathway to hepatocellular carcinoma.Cancer cell, 16 4
H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, W. Heim, J. Berlin, A. Baron, S. Griffing, E. Holmgren, N. Ferrara, G. Fyfe, B. Rogers, R. Ross, F. Kabbinavar (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.The New England journal of medicine, 350 23
Yong Tao, Jue Ruan, S. Yeh, Xuemei Lu, Yu Wang, W. Zhai, Jun Cai, Shaoping Ling, Q. Gong, Zechen Chong, Zhengzhong Qu, Qianqian Li, Jiang Liu, Jin Yang, Caihong Zheng, Changqing Zeng, Hurng‐Yi Wang, Jing Zhang, Shenggang Wang, Lingtong Hao, Lili Dong, Wenjie Li, Min Sun, Weilong Zou, Caixia Yu, Chaohua Li, Guojing Liu, Lan Jiang, Jin Xu, Huanwei Huang, Chunyan Li, S. Mi, Bing Zhang, Baoxiang Chen, Wenming Zhao, Songnian Hu, Shi‐Mei Zhuang, Yang Shen, S. Shi, Christopher Brown, K. White, Ding‐Shinn Chen, Pei‐Jer Chen, Chung-I Wu (2011)
Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome dataProceedings of the National Academy of Sciences, 108
Jing Xu, Hui Xu, Qing Zhang, Fei Song, Jian-Li Jiang, Xiang-min Yang, Lisyany Mi, Ning Wen, R. Tian, Li Wang, H. Yao, Q. Feng, Yang Zhang, J. Xing, P. Zhu, Zhi-Nan Chen (2007)
HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular CarcinomaMolecular Cancer Research, 5
H. Uchida, Y. Iwashita, A. Sasaki, K. Shibata, Toshifumi Matsumoto, M. Ohta, S. Kitano (2006)
Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 21
Gastroenterology – Unpaywall
Published: Mar 1, 2013
Access the full text.
Sign up today, get DeepDyve free for 14 days.